Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2
Jim Baggen(Rega Institute for Medical Research), Leentje Persoons(Rega Institute for Medical Research), Els Vanstreels(Rega Institute for Medical Research), Sander Jansen(Rega Institute for Medical Research), Dominique Van Looveren(Rega Institute for Medical Research), Bram Boeckx(VIB-KU Leuven Center for Cancer Biology), Vincent Geudens(KU Leuven), Julie De Man(Rega Institute for Medical Research), Dirk Jochmans(Rega Institute for Medical Research), Joost Wauters(KU Leuven), Els Wauters(KU Leuven), Bart Vanaudenaerde(KU Leuven), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Johan Neyts(Rega Institute for Medical Research), Kai Dallmeier(Rega Institute for Medical Research), Hendrik Jan Thibaut(Rega Institute for Medical Research), Maarten Jacquemyn(Rega Institute for Medical Research), Piet Maes(Rega Institute for Medical Research), Dirk Daelemans(Rega Institute for Medical Research)
Cited by 235Open Access